Chemomab Therapeutics Ltd. (CMMB) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative Expenses
0625K1M2M2M3M4M4M5MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-5M-4M-4M-3M-2M-2M-1M-625K1Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

Revenue Variation (%)

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
048111519222630Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
01122344556687990Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
075K150K225K300K375K450K525K600KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash Flow to Debt Ratio

🏦 Balance Sheet
📈 Key Metrics